Bromoacetylalprenololmenthane
![]() | |
| Names | |
|---|---|
| IUPAC name
2-bromo-N-[2-[4-[[2-hydroxy-3-(2-prop-2-enylphenoxy)propyl]amino]-4-methylcyclohexyl]propan-2-yl]acetamide | |
| Identifiers | |
| 76298-89-0 82870-40-4 | |
| Abbreviations | BAAM, BrAAM |
| ChEMBL | ChEMBL46136 |
| ChemSpider | 112852 |
| Jmol interactive 3D | Image Image |
| MeSH | Bromoacetylalprenololmenthane |
| PubChem | 127126 |
| |
| |
| Properties | |
| C24H37BrN2O3 | |
| Molar mass | 481.48 g·mol−1 |
| log P | 4.14 |
| Acidity (pKa) | 13.844 |
| Basicity (pKb) | 0.153 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Bromoacetylalprenololmenthane (BAAM or BrAAM) is a β adrenergic receptor agonist.[1]
References
- ↑ Rainer-Joachim; Matthys Staehelin (20 April 1987). "Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells". FEBS Letters 214 (2): 323–326. doi:10.1016/0014-5793(87)80079-0.
This article is issued from Wikipedia - version of the Monday, March 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
